Monday Morning Oncology Journal Club

Monday Morning Oncology Journal Club

3455 321

7:30-8:30 AM

CHOMP 

Medical Staff conference room #1

                                May 2024 

May 6         Not Today

No Journal Club

May 13    A.I. in Medicine: Enjoy your job while you still have it

                    TBA

                                    -David Gardner

May 20   EGFR mutated lung cancer – What’s after osimertinib?

“Phase III Randomized Study of Atezolizumab plus Bevacizumab and Chemotherapy in Patients with EGFR- or ALK-Mutated NSCLC (ATTLAS)

                                    Park S, Kim T, Han J et al.  JCO  April 10^th, 2024

“Nivolumab Plus Chemotherapy in EGFR-Mutated Metastatic NSCLC after Disease Progression on EGFR TKIs: Final Results of CheckMate 722”

                                                Mok T, Nakagawa K, Park K et al. .JCO April 10^th, 2024

ONCOLOGY GRAND ROUNDS:  “Management of Treatment Resistance in Patients with Advanced EGFR-Mutated Lung Cancer”

            Vallillo A, Viray H, Feldman J et al. JCO April 10^th, 2024

                -John Hausdorff

May 27    Memorial Day